Pharmaceutical manufacturing

FILE - In this Tuesday, July 16, 2019, file photo, Health and Human Services Secretary Alex Azar pauses while speaking during a Cabinet meeting at the White House, in Washington. Azar says he and President Donald Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 10:35 am
WASHINGTON (AP) — The Trump administration said Wednesday it will set up a system allowing Americans to legally and safely import lower-cost prescription drugs from Canada for the first time, reversing years of opposition from federal health authorities amid a public outcry over high prices for...
Read More
FILE - In this Tuesday, July 16, 2019, file photo, Health and Human Services Secretary Alex Azar pauses while speaking during a Cabinet meeting at the White House, in Washington. Azar says he and President Donald Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 6:41 am
WASHINGTON (AP) — The Trump administration is working on a plan that would allow Americans to import lower-priced prescription drugs from Canada, Health and Human Services Secretary Alex Azar says. Azar made his comments on Tuesday during an interview with CNBC, saying he had just gotten off the...
Read More
FILE - In this Wednesday, July 10, 2019, file photo, President Donald Trump speaks about kidney health, accompanied by Health and Human Services Secretary Alex Azar, left, in Washington. Azar says he and Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 12:44 am
WASHINGTON (AP) — The Trump administration is working on a plan that would allow Americans to import lower-priced prescription drugs from Canada, Health and Human Services Secretary Alex Azar said Tuesday. Azar made his comments during an interview with CNBC, saying he had just gotten off the phone...
Read More
FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports earnings Friday, Feb. 1, 2019. Merck & Co., Inc. reports financial results on Tuesday, July 30, 2019. (AP Photo/Seth Wenig, File)
July 30, 2019 - 2:31 pm
Soaring sales of its cancer blockbuster and vaccines helped drive Merck's second-quarter profit up a whopping 54%, blowing past Wall Street expectations. The maker of cancer immunotherapy drug Keytruda and diabetes pill Januvia also benefited from slightly reduced spending on research and...
Read More
FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports earnings Friday, Feb. 1, 2019. Merck & Co., Inc. reports financial results on Tuesday, July 30, 2019. (AP Photo/Seth Wenig, File)
July 30, 2019 - 7:55 am
Soaring sales of its cancer blockbuster and vaccines helped drive Merck's second-quarter profit up a whopping 54%, blowing past Wall Street expectations and cheering investors. The maker of cancer immunotherapy drug Keytruda and diabetes pill Januvia also benefited from reduced spending on research...
Read More
FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports earnings Friday, Feb. 1, 2019. Merck & Co., Inc. reports financial results on Tuesday, July 30, 2019. (AP Photo/Seth Wenig, File)
July 30, 2019 - 7:00 am
KENILWORTH, N.J. (AP) — Merck is reporting a 12% jump in global sales, pushing it past profit expectations for the second quarter. The pharmaceutical company reported a profit of $2.67 billion, or $1.03 per share. Earnings, adjusted for costs related to mergers and acquisitions and restructuring...
Read More
FILE - In this June 18, 2019, file photo, U.S. Trade Representative Robert Lighthizer testifies before the Senate Finance Committee on Capitol Hill in Washington. Congressional Democrats appear to be moving from “no way’’ to “maybe’’ on President Donald Trump’s rewrite of a trade pact with Canada and Mexico. House Democrats have met four times with Lighthizer, most recently on Friday, July 26, and both sides say they are making progress toward a deal that would clear the way for Congress to approve Trump’s U.S.-Mexico-Canada Agreement, or USMCA. (AP Photo/Susan Walsh, File)
July 30, 2019 - 12:30 am
WASHINGTON (AP) — Congressional Democrats appear to be moving from "no way" to "maybe" on President Donald Trump's rewrite of a trade pact with Canada and Mexico. House Democrats have met four times with U.S. Trade Representative Robert Lighthizer, most recently on Friday, and both sides say they...
Read More
FILE - In this July 8, 2016, file photo, a prescription is filled at Pucci's Pharmacy in Sacramento, Calif. Four pharmaceutical companies are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high. California Attorney General Xavier Becerra said Monday, July 29, 2019, that the bulk of the money will come from Teva Pharmaceutical Industries for paying to delay a generic narcolepsy drug from entering the market for nearly six years. (AP Photo/Rich Pedroncelli, File)
July 29, 2019 - 6:47 pm
SACRAMENTO, Calif. (AP) — Three pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday. The bulk of the money will come from Teva Pharmaceutical...
Read More
FILE - In this July 22, 2019, file photo trader William Lawrence works on the floor of the New York Stock Exchange. U.S. stocks moved lower in early trading on Wall Street Monday, July 29, as investors pulled back after pushing stocks to record highs last week. (AP Photo/Richard Drew, File)
July 29, 2019 - 4:54 pm
Major U.S. stock indexes closed mostly lower Monday as investors turned cautious ahead of a key Federal Reserve interest policy announcement and other potentially market-moving developments on tap for this week. Banks, retailers and communications companies took the brunt of the selling. Those...
Read More
FILE - In this July 8, 2016, file photo, a prescription is filled at Pucci's Pharmacy in Sacramento, Calif. Four pharmaceutical companies are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high. California Attorney General Xavier Becerra said Monday, July 29, 2019, that the bulk of the money will come from Teva Pharmaceutical Industries for paying to delay a generic narcolepsy drug from entering the market for nearly six years. (AP Photo/Rich Pedroncelli, File)
July 29, 2019 - 4:26 pm
SACRAMENTO, Calif. (AP) — Four pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday. The bulk of the money will come from Teva Pharmaceutical...
Read More

Pages